PCSK9 and coronary artery disorder: Genetically-instrumented lower PCSK9 concentration was associated with a lower risk of CHD, HF, and CKD, and additionally with any stroke, ischemic stroke, AF, MS, as well as an increased risk of asthma and AD18.